Share General Information
Methylergometrine, the active ingredient of methylergometrine maleate, is a semi-synthetic equivalent of the naturally occurring alkaloid ergonovine. It belongs to the class of drugs termed oxytocics, which stimulate contraction of the smooth muscle fibers of the uterus. A potent oxytocic, methylergometrine is used to prevent or control excessive bleeding resulting from vaginal childbirth or abortion. It is also used for routine management after delivery of the placenta, postpartum atony (loss of tone or tension), and subinvolution (failure of the uterus to return to its normal size following childbirth). Under full obstetric supervision, it may be administered in the second stage of labor following delivery of the anterior shoulder. The onset of action depends on mode of administration (intravenous injectable, immediate; intramuscular injectable, 2-5 minutes; oral administration, 5-10 minutes).
About the API
-
Japan DMF
-
Korea DMF
-
US DMF
The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.
For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.
